FlagInternationalUnited States
 

Corporate Governance - Management

Rob Kill
President and CEO
Rob Kill
President and CEO


Rob Kill was named President and CEO of Uroplasty, Inc. in July 2013 and has served on the Board of Directors since 2010. He also serves as an Operating Partner of Altamont Capital Partners, a private equity firm with over $1 billion in capital. Prior to Uroplasty, Mr. Kill served as Chairman & CEO of Virtual Radiologic Corporation, a telemedicine provider of technology-enabled outsourced radiology solutions to over 2,500 hospitals. Before joining Virtual Radiologic, he was President of Misys... 
Brett Reynolds
Chief Financial Officer
Brett Reynolds
Chief Financial Officer


Brett Reynolds has been Uroplasty’s Senior Vice President and Chief Financial Officer since August 2013. From 2005 until its acquisition by Baxter International Inc. in February 2012, Mr. Reynolds was the Chief Financial Officer and Vice President of Finance of Synovis Life Technologies, Inc., a publicly-held medical device manufacturer headquartered in the St. Paul, MN. From 2012 until becoming an officer of Uroplasty, Mr. Reynolds was the site leader of Baxter in the Twin Cities responsible f... 
Darin Hammers
Senior Vice President of Global Sales and Marketing
Darin Hammers
Senior Vice President of Global Sales and Marketing


Darin Hammers, Senior Vice President of Sales and Marketing, joined Uroplasty in January 2013. He was most recently a Vice President of Sales for Bard Medical Divisions, of CR Bard based in Covington, GA, focused on Urology care products. Prior to that, Mr. Hammers spent more than 12 years with Boston Scientific in various sales leadership positions in the Urology/Gynecology areas. Mr. Hammers holds a BS in Marketing from the University of Southern Indiana and received his MBA from Emory Univers... 
Marc M. Herregraven
Vice President of Manufacturing
Marc M. Herregraven
Vice President of Manufacturing


Marc M. Herregraven has served as our Vice President of Manufacturing since November 2002. He joined Bioplasty, Inc. in April 1992 as Plant Manager, and became Director of Manufacturing in 1994 and Director of Operations in 1999. Previously, he served with Advanced Bio-Surfaces, Inc., a Minnesota-based medical device developer, as Director of Manufacturing, and with Bio-Vascular, Inc., a Minnesota-based medical device manufacturer, in an engineering function. Mr. Herregraven has a Bachelor of Sc... 
Dan Merz
Vice President of Healthcare Affairs
Dan Merz
Vice President of Healthcare Affairs


Dan Merz has joined Uroplasty as the Vice President of Healthcare Affairs in April 2014. In this role, he oversees Uroplasty’s efforts to gain global coverage for PTNS and Macroplastique therapies through the strategic development and demonstration of the efficiency, effectiveness and overall value of the Company’s products to payers and providers. He joins Uroplasty with fifteen years of medical device experience at various levels of management, specifically in driving commercial success throu... 
Dave Perry
Vice President of Marketing
Dave Perry
Vice President of Marketing


Dave Perry joined Uroplasty as the Vice President of Marketing in December 2013 with nearly 20 years of experience developing, branding and commercializing medical device products. His experience includes more than 10 years directing domestic and global product marketing initiatives in the endourology, prostate and men's health divisions at American Medical Systems (AMS), an Endo Health Solutions company. Prior to joining AMS, Mr. Perry held key marketing roles at Boston Scientific Scimed and K... 
Dr. Suranjan  Roychowdhury
Vice President of Research & Development and Clinical Affairs
Dr. Suranjan  Roychowdhury
Vice President of Research & Development and Clinical Affairs


Dr. Suranjan Roychowdhury joined Uroplasty as Vice President of Research & Development and Clinical Affairs in January 2014. This newly created position within the Uroplasty organization was established to provide focus, oversight and guidance to the Company's product pipeline and clinical trials. Dr. Roychowdhury has more than 20 years of functional leadership experience and success in the development and commercialization of implantable and disposable medical devices. Dr. Roychowdhury served...